Meyer T S, Mieny C J
Departement Chirurgie, Universiteit van Pretoria en H. F. Verwoerd-hospitaal.
S Afr J Surg. 1990 Jun;28(2):66-7.
There are at present four different approaches to the management of lobular carcinoma in situ. (i) ipsilateral mastectomy with contralateral biopsy; (ii) ipsilateral segmental excision with block dissection of the axilla; (iii) bilateral mastectomy; and (iv) diagnostic excision biopsy and lifelong follow-up of both breasts with clinical examination and mammography. There are arguments in favour and against all four approaches. Based on the well-established fact that the risk of the patient developing infiltrating lobular carcinoma is equal in both breasts, the most rational approach is excisional diagnostic biopsy of the known lesion and lifelong follow-up of both breasts. Any infiltrating carcinoma will be discovered early with this approach, and the 20-year survival is 95%. If the patient insists that the risk of developing carcinoma must be totally excluded, bilateral mastectomy with breast reconstruction is the only option.
目前,对于小叶原位癌有四种不同的治疗方法。(i)患侧乳房切除术加对侧活检;(ii)患侧乳腺区段切除术加腋窝淋巴结整块清扫术;(iii)双侧乳房切除术;(iv)诊断性切除活检并对双侧乳房进行终身随访,包括临床检查和乳房X线摄影。对于这四种方法都存在支持和反对的观点。基于双侧乳房发生浸润性小叶癌的风险相等这一已被充分证实的事实,最合理的方法是对已知病变进行切除诊断活检并对双侧乳房进行终身随访。采用这种方法,任何浸润性癌都能被早期发现,20年生存率为95%。如果患者坚持必须完全排除患癌风险,那么双侧乳房切除加乳房重建是唯一的选择。